Molecular epigenetic targets for liver diseases: current challenges and future prospects Robert Zeidler et al, 2017, Drug Discovery Today CrossRef
The Notch ligand delta-like 3 promotes tumor growth and inhibits Notch signaling in lung cancer cells in mice San-Ming Deng et al, 2017, Biochemical and Biophysical Research Communications CrossRef
Differential expression of the Notch1 receptor, and its ligands Dll1, Dll3 and Dll4 in distinct human pituitary adenoma subtypes Jianfu Zhang et al, 2017 CrossRef
Oncogenic role of the Notch pathway in primary liver cancer JIE LU et al, 2016 CrossRef
Delta-like 3 is silenced by HBx via histone acetylation in HBV-associated HCCs Hiroki Hamamoto et al, 2018, Sci Rep CrossRef
Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV-related liver diseases Libo Sun et al, 2018, Cancer Med CrossRef
Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer Juan Wang et al, 2018, Medicine CrossRef
Knockdown of Delta-like 3 restricts lipopolysaccharide-induced inflammation, migration and invasion of A2058 melanoma cells via blocking Twist1-mediated epithelial-mesenchymal transition Xiaojie Ding et al, 2019, Life Sciences CrossRef
DLL
3 regulates the migration and invasion of small cell lung cancer by modulating Snail
Megumi Furuta et al, 2019, Cancer Sci CrossRef
A functional and protein-protein interaction analysis of neuroepithelial cell transforming gene 1 in hepatocellular carcinoma Ke Ye et al, 2014, Tumor Biol. CrossRef
Delta‐like 3 localizes to neuroendocrine cells and plays a pivotal role in gastrointestinal neuroendocrine malignancy Kentaro Matsuo et al, 2019, Cancer Sci CrossRef
A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism Anu Loukola et al, 2015, PLoS Genet CrossRef
DLL3 expression in Large Cell Neuroendocrine Carcinoma (LCNEC) and Association with Molecular Subtypes and Neuroendocrine Profile B.C.M. Hermans et al, 2019, Lung Cancer CrossRef
The Role of DLLs in Cancer: A Novel Therapeutic Target
ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression Xin Wang et al, 2016, Oncotarget CrossRef
Delta-like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview. Kentaro Matsuo et al, 2021, Cancer Sci CrossRef
Elevated DLL3 in stomach cancer by tumor-associated macrophages enhances cancer-cell proliferation and cytokine secretion of macrophages Jian-Bin Ye et al, 2021 CrossRef
DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis Humaira Noor et al, 2022, Genomics CrossRef
Methylation‑associated inactivation of JPH3 and its effect on prognosis and cell biological function in HCC Yi Huang et al, 2022, Mol Med Rep CrossRef
Diagnostic and prognostic value of STAP1 and AHNAK methylation in peripheral blood immune cells for HBV-related hepatopathy Libo Sun et al, 2023, Front. Immunol. CrossRef
Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma Jinyu Xiang et al, 2023, Front. Genet. CrossRef
Advances in new targets for immunotherapy of small cell lung cancer Zitong Zheng et al, 2023, Thoracic Cancer CrossRef
Methylation Patterns and Chromatin Accessibility in Neuroendocrine Lung Cancer Elsa Arbajian et al, 2020, Cancers CrossRef
DLL3 as a Potential Diagnostic and Therapeutic Target in Neuroendocrine Neoplasms: A Narrative Review Annarita Peddio et al, 2024, Critical Reviews in Oncology/Hematology CrossRef